Sub-4 min mile runners have increased longevity compared with the general population

To build or to buy? That’s a clas­sic ques­tion for phar­ma board­rooms, and No­vo Nordisk is go­ing with both. Be­yond spend­ing bil­lions of dol­lars to

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

The Glob­al Health Mar­ket­ing & Com­mu­ni­ca­tions (GHMC) phar­ma and health­care agency net­work is go­ing south to Mex­i­co and Latin Amer­i­ca with its lat­est part­ner ad­di­tion.